These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15781405)

  • 1. Novel A-ring analogs of the hormone 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation.
    Posner GH; Lee SH; Kim HJ; Peleg S; Dolan P; Kensler TW
    Bioorg Med Chem; 2005 Apr; 13(8):2959-66. PubMed ID: 15781405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel A-ring homodimeric C-3-carbamate analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation.
    Oves D; Fernández S; Verlinden L; Bouillon R; Verstuyf A; Ferrero M; Gotor V
    Bioorg Med Chem; 2006 Nov; 14(22):7512-9. PubMed ID: 16879968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
    Verstuyf A; Verlinden L; Van Baelen H; Sabbe K; D'Hallewyn C; De Clercq P; Vandewalle M; Bouillon R
    J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
    Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
    Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly antiproliferative, low-calcemic, side-chain ketone analogs of the hormone 1alpha,25-dihydroxyvitamin D3.
    Posner GH; Kim HJ; Kahraman M; Jeon HB; Suh BC; Li H; Dolan P; Kensler TW
    Bioorg Med Chem; 2005 Oct; 13(19):5569-80. PubMed ID: 16039132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel vitamin D3 antipsoriatic antedrugs: 16-En-22-oxa-1alpha,25-(OH)2D3 analogs.
    Shimizu K; Kawase A; Haneishi T; Kato Y; Kobayashi T; Sekiguchi N; Yamamoto T; Ishigai M; Tokuda K; Matsushita T; Shimaoka S; Morikawa K
    Bioorg Med Chem; 2006 Mar; 14(6):1838-50. PubMed ID: 16307885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
    Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
    Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-ring hydroxymethyl 19-nor analogs of the natural hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.
    Hatcher MA; Peleg S; Dolan P; Kensler TW; Sarjeant A; Posner GH
    Bioorg Med Chem; 2005 Jun; 13(12):3964-76. PubMed ID: 15878279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of previtamin D(3) analogues with A-ring modifications.
    Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M
    Bioorg Med Chem; 2008 Dec; 16(24):10244-50. PubMed ID: 19006670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Versatile synthesis and biological evaluation of 1,3-diamino-substituted 1alpha,25-dihydroxyvitamin D3 analogues.
    Oves D; Fernández S; Ferrero M; Bouillon R; Verstuyf A; Gotor V
    Bioorg Med Chem; 2006 Feb; 14(4):928-37. PubMed ID: 16213141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
    Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K
    J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difluoromethyl analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: Design, synthesis, and preliminary biological evaluation.
    Posner GH; Suh BC; Petersen KS; Dolan P; Agoston ES; Kensler TW; Koh JT; Peleg S
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):213-21. PubMed ID: 17218093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
    Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
    J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D3 analogues with aromatic side chains attached at C-17.
    Liu C; Zhao GD; Mao X; Suenaga T; Fujishima T; Zhang CM; Liu ZP
    Eur J Med Chem; 2014 Oct; 85():569-75. PubMed ID: 25127149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
    Kato Y; Nakano Y; Sano H; Tanatani A; Kobayashi H; Shimazawa R; Koshino H; Hashimoto Y; Nagasawa K
    Bioorg Med Chem Lett; 2004 May; 14(10):2579-83. PubMed ID: 15109656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preliminary biological evaluation of new antiproliferative aromatic analogues of 1α,25-dihydroxyvitamin D3.
    Thomas E; Brion JD; Peyrat JF
    Eur J Med Chem; 2014 Oct; 86():381-93. PubMed ID: 25180926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative, low-calcemic, fluorinated sulfone analogs of 1alpha,25-dihydroxyvitamin D3: chemical synthesis and biological evaluation.
    Usera AR; Dolan PM; Kensler TW; Posner GH
    Bioorg Med Chem; 2007 Aug; 15(16):5509-18. PubMed ID: 17560112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
    Shimizu M; Miyamoto Y; Kobayashi E; Shimazaki M; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem; 2006 Jun; 14(12):4277-94. PubMed ID: 16503143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
    Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.